BTBP: Reviewed the third quarterly report, adjusted the structure, and acquired 1% equity in Songzi Pulp Station

BTBP announced that the 26th meeting of the 9th Board of Directors, held on October 23, 2025, reviewed several proposals. First, it approved the "Q3 2025 Report"; second, it agreed to abolish the Blood Source Management Center and establish the Blood Source Management Department and Blood Source Management Region; third, it agreed that its subsidiary, TianTan Wuhan, would acquire 1% equity of Songzi Plasma Station for 222,660 yuan, after which it will hold 100% equity; fourth, it approved the proposal to authorize the general manager's office to make decisions on pre-approval matters related to economic activities